WASHINGTON, April 18, 2019 /PRNewswire/ -- Vanda
Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced it will
release results for the first quarter 2019 on Wednesday, May 1, 2019, after the market closes.
Vanda will host a conference call at 4:30
PM ET on Wednesday, May 1, 2019, during which management
will discuss the first quarter 2019 financial results and other
corporate activities. To participate in the conference call, please
dial 1-866-688-9426 (domestic) or 1-409-216-0816 (international)
and use passcode 6195579.
The conference call will be broadcast simultaneously and
archived on Vanda's website, www.vandapharma.com. Investors should
go to the website at least 15 minutes early to register, download,
and install any necessary audio software.
A replay of the call will be available on Wednesday, May 1, 2019, beginning at 7:30 PM ET and will be accessible until
Wednesday, May 8, 2019, at
11:59 PM ET. The replay call-in
number is 1-855-859-2056 for domestic callers and 1-404-537-3406
for international callers. The passcode number is
6195579.
ABOUT VANDA PHARMACEUTICALS INC.:
Vanda is a global
biopharmaceutical company focused on the development and
commercialization of innovative therapies to address high unmet
medical needs and improve the lives of patients. For more on Vanda
Pharmaceuticals Inc., please visit www.vandapharma.com.
Investor Contact:
Jim
Kelly
Executive Vice President & Chief Financial Officer
Vanda Pharmaceuticals Inc.
(202) 734-3428
jim.kelly@vandapharma.com
View original
content:http://www.prnewswire.com/news-releases/vanda-pharmaceuticals-to-announce-first-quarter-2019-financial-results-on-may-1-2019-300834885.html
SOURCE Vanda Pharmaceuticals Inc.